Detailed information for compound 207947

Basic information

Technical information
  • TDR Targets ID: 207947
  • Name: 1-[(6-heptyl-2H-chromen-3-yl)methyl]-1-hydrox yurea
  • MW: 318.411 | Formula: C18H26N2O3
  • H donors: 2 H acceptors: 2 LogP: 3.54 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCCCCc1ccc2c(c1)C=C(CO2)CN(C(=O)N)O
  • InChi: 1S/C18H26N2O3/c1-2-3-4-5-6-7-14-8-9-17-16(10-14)11-15(13-23-17)12-20(22)18(19)21/h8-11,22H,2-7,12-13H2,1H3,(H2,19,21)
  • InChiKey: ZVLVTOCEPANPQW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[(6-heptyl-2H-chromen-3-yl)methyl]-1-hydroxy-urea
  • 1-[(6-heptyl-2H-1-benzopyran-3-yl)methyl]-1-hydroxyurea

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens arachidonate 5-lipoxygenase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum IPR001024,Lipoxygenase, LH2;IPR013819,Lipoxygenase, C-terminal,domain-containing Get druggable targets OG5_127482 All targets in OG5_127482
Echinococcus granulosus arachidonate 5 lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482
Schistosoma japonicum ko:K00461 arachidonate 5-lipoxygenase [EC1.13.11.34], putative Get druggable targets OG5_127482 All targets in OG5_127482
Schistosoma mansoni lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482
Echinococcus multilocularis arachidonate 5 lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482
Schistosoma mansoni lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni lipoxygenase 0.0142 0.4826 0.3453
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0069 0.0147 0.0149
Echinococcus granulosus nmda type glutamate receptor 0.017 0.6562 0.6609
Echinococcus multilocularis nmda type glutamate receptor 0.017 0.6562 0.666
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0069 0.0147 0.0149
Echinococcus multilocularis glutamate receptor NMDA 0.0155 0.5609 0.5693
Echinococcus granulosus arachidonate 5 lipoxygenase 0.0142 0.4826 0.4821
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0069 0.0147 0.0149
Echinococcus multilocularis nmda type glutamate receptor 0.0221 0.9853 1
Echinococcus multilocularis glutamate receptor 2 0.0069 0.0147 0.0149
Echinococcus granulosus nmda type glutamate receptor 0.0221 0.9853 1
Echinococcus granulosus glutamate receptor NMDA 0.0155 0.5609 0.5628
Echinococcus multilocularis glutamate receptor, ionotrophic, AMPA 3 0.0069 0.0147 0.0149
Echinococcus multilocularis arachidonate 5 lipoxygenase 0.0142 0.4826 0.4898

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.31 uM In vitro inhibitory activity against 5-lipoxygenase by reduction of 5-hydroxyeicosatetraenoic acid (5-HETE) formed in guinea pig polymorphonuclear leukocytes (PMNs). ChEMBL. 8246226
IC50 (binding) = 0.31 uM In vitro inhibitory activity against 5-lipoxygenase by reduction of 5-hydroxyeicosatetraenoic acid (5-HETE) formed in guinea pig polymorphonuclear leukocytes (PMNs). ChEMBL. 8246226
IC50 (binding) = 0.37 uM In vitro inhibitory activity against 5-lipoxygenase by reduction of LTB4 formed in guinea pig polymorphonuclear leukocytes (PMNs). ChEMBL. 8246226
IC50 (binding) = 0.37 uM In vitro inhibitory activity against 5-lipoxygenase by reduction of LTB4 formed in guinea pig polymorphonuclear leukocytes (PMNs). ChEMBL. 8246226
Inhibition (functional) = % Ex vivo inhibition of LTB4 production by measurement of A-23,187-stimulated LTB-4 production in dog blood at 1 mg/kg po. ChEMBL. 8246226
Inhibition (functional) = 0 % Ex vivo inhibition of LTB4 production by measurement of A-23,187-stimulated LTB-4 production in dog blood at 1 mg/kg po. ChEMBL. 8246226

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.